The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS patient brains

  1. Erin G Conlon
  2. Lei Lu
  3. Aarti Sharma
  4. Takashi Yamazaki
  5. Timothy Tang
  6. Neil A Shneider  Is a corresponding author
  7. James L Manley  Is a corresponding author
  1. Columbia University, United States
  2. Columbia University Medical Center, United States

Abstract

An expanded GGGGCC hexanucleotide in C9ORF72 (C9) is the most frequent known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It has been proposed that expanded transcripts adopt G-quadruplex (G-Q) structures and associate with proteins, but whether this occurs and contributes to disease is unknown. Here we show first that the protein that predominantly associates with GGGGCC repeat RNA in vitro is the splicing factor hnRNP H, and that this interaction is linked to G-Q formation. We then show that G-Q RNA foci are more abundant in C9 ALS patient fibroblasts and astrocytes compared to those without the expansion, and more frequently colocalize with hnRNP H. Importantly, we demonstrate dysregulated splicing of multiple known hnRNP H-target transcripts in C9 patient brains, which correlates with elevated insoluble hnRNP H/G-Q aggregates. Together, our data implicate C9 expansion-mediated sequestration of hnRNP H as a significant contributor to neurodegeneration in C9 ALS/FTD.

Data availability

The following previously published data sets were used

Article and author information

Author details

  1. Erin G Conlon

    Department of Biological Sciences, Columbia University, New York, United States
    Competing interests
    No competing interests declared.
  2. Lei Lu

    Department of Neurology, Columbia University Medical Center, New York, United States
    Competing interests
    No competing interests declared.
  3. Aarti Sharma

    Department of Neurology, Columbia University Medical Center, New York, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4907-2174
  4. Takashi Yamazaki

    Department of Biological Sciences, Columbia University, New York, United States
    Competing interests
    No competing interests declared.
  5. Timothy Tang

    Department of Biological Sciences, Columbia University, New York, United States
    Competing interests
    No competing interests declared.
  6. Neil A Shneider

    Department of Neurology, Columbia University Medical Center, New York, United States
    For correspondence
    ns327@columbia.edu
    Competing interests
    No competing interests declared.
  7. James L Manley

    Department of Biological Sciences, Columbia University, New York, United States
    For correspondence
    jlm2@columbia.edu
    Competing interests
    James L Manley, Senior editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8341-1459

Funding

NIH Office of the Director (Training Grant)

  • Erin G Conlon

NIH Office of the Director (RO1)

  • James L Manley

NIH Office of the Director (R35 GM 118136)

  • James L Manley

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Douglas L Black, University of California, Los Angeles, United States

Ethics

Human subjects: Informed consent, including consent to publish, was obtained for human derived fibroblast and astrocyte lines used in this study by the IRB of Columbia University under protocols #AAAB0483 and #AAAC1257. For fibroblasts, written consent was given by the patients, and for astrocytes, written consent was given by the families of the deceased. Human tissue was donated for research purposes by the next of kin.

Version history

  1. Received: May 13, 2016
  2. Accepted: September 8, 2016
  3. Accepted Manuscript published: September 13, 2016 (version 1)
  4. Accepted Manuscript updated: September 14, 2016 (version 2)
  5. Accepted Manuscript updated: September 17, 2016 (version 3)
  6. Accepted Manuscript updated: September 21, 2016 (version 4)
  7. Version of Record published: October 4, 2016 (version 5)
  8. Version of Record updated: October 7, 2016 (version 6)
  9. Version of Record updated: October 10, 2016 (version 7)

Copyright

© 2016, Conlon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,048
    Page views
  • 1,773
    Downloads
  • 201
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Erin G Conlon
  2. Lei Lu
  3. Aarti Sharma
  4. Takashi Yamazaki
  5. Timothy Tang
  6. Neil A Shneider
  7. James L Manley
(2016)
The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS patient brains
eLife 5:e17820.
https://doi.org/10.7554/eLife.17820

Share this article

https://doi.org/10.7554/eLife.17820

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Karolina Honzejkova, Dalibor Kosek ... Tomas Obsil
    Research Article

    Apoptosis signal-regulating kinase 1 (ASK1) is a crucial stress sensor, directing cells toward apoptosis, differentiation, and senescence via the p38 and JNK signaling pathways. ASK1 dysregulation has been associated with cancer and inflammatory, cardiovascular, and neurodegenerative diseases, among others. However, our limited knowledge of the underlying structural mechanism of ASK1 regulation hampers our ability to target this member of the MAP3K protein family towards developing therapeutic interventions for these disorders. Nevertheless, as a multidomain Ser/Thr protein kinase, ASK1 is regulated by a complex mechanism involving dimerization and interactions with several other proteins, including thioredoxin 1 (TRX1). Thus, the present study aims at structurally characterizing ASK1 and its complex with TRX1 using several biophysical techniques. As shown by cryo-EM analysis, in a state close to its active form, ASK1 is a compact and asymmetric dimer, which enables extensive interdomain and interchain interactions. These interactions stabilize the active conformation of the ASK1 kinase domain. In turn, TRX1 functions as a negative allosteric effector of ASK1, modifying the structure of the TRX1-binding domain and changing its interaction with the tetratricopeptide repeats domain. Consequently, TRX1 reduces access to the activation segment of the kinase domain. Overall, our findings not only clarify the role of ASK1 dimerization and inter-domain contacts but also provide key mechanistic insights into its regulation, thereby highlighting the potential of ASK1 protein-protein interactions as targets for anti-inflammatory therapy.

    1. Biochemistry and Chemical Biology
    Jake W Anderson, David Vaisar ... Natalie G Ahn
    Research Article

    Activation of the extracellular signal-regulated kinase-2 (ERK2) by phosphorylation has been shown to involve changes in protein dynamics, as determined by hydrogen-deuterium exchange mass spectrometry (HDX-MS) and NMR relaxation dispersion measurements. These can be described by a global exchange between two conformational states of the active kinase, named ‘L’ and ‘R,’ where R is associated with a catalytically productive ATP-binding mode. An ATP-competitive ERK1/2 inhibitor, Vertex-11e, has properties of conformation selection for the R-state, revealing movements of the activation loop that are allosterically coupled to the kinase active site. However, the features of inhibitors important for R-state selection are unknown. Here, we survey a panel of ATP-competitive ERK inhibitors using HDX-MS and NMR and identify 14 new molecules with properties of R-state selection. They reveal effects propagated to distal regions in the P+1 and helix αF segments surrounding the activation loop, as well as helix αL16. Crystal structures of inhibitor complexes with ERK2 reveal systematic shifts in the Gly loop and helix αC, mediated by a Tyr-Tyr ring stacking interaction and the conserved Lys-Glu salt bridge. The findings suggest a model for the R-state involving small movements in the N-lobe that promote compactness within the kinase active site and alter mobility surrounding the activation loop. Such properties of conformation selection might be exploited to modulate the protein docking interface used by ERK substrates and effectors.